2002
DOI: 10.1006/rtph.2002.1562
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the LOAEL-to-NOAEL Uncertainty Factor for Mild Adverse Effects from Acute Inhalation Exposures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
40
0
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 57 publications
(42 citation statements)
references
References 15 publications
1
40
0
1
Order By: Relevance
“…viridiflorum water extract was toxic (LD 50 1000 mg/ kg body weight); however, no mortality or signs of toxicity were observed for the rest of the water extracts after oral administration of a single dose at any dose level up to the highest dose tested (5000 mg/kg) which was the no-observed-adverse-effect level (NOAEL) (Alexeeff et al, 2002).…”
Section: Resultsmentioning
confidence: 97%
“…viridiflorum water extract was toxic (LD 50 1000 mg/ kg body weight); however, no mortality or signs of toxicity were observed for the rest of the water extracts after oral administration of a single dose at any dose level up to the highest dose tested (5000 mg/kg) which was the no-observed-adverse-effect level (NOAEL) (Alexeeff et al, 2002).…”
Section: Resultsmentioning
confidence: 97%
“…The mortality rate of 0% at a dose of 100 mg/kg gradually rose to 100% at 8000 mg/kg, the highest dose studied. The no-observed-adverse-effect level for the intraperitoneal dose was 500 mg/kg, while the lowest-observed-effects level was 750 mg/kg (Alexeeff et al, 2002). Some adverse effects, such as hypoactivity and salivation, were seen immediately after intraperitoneal injection, while others (e.g., anorexia and weight loss) were observed later, and were more pronounced at the highest doses and persisted until death ( Table 2).…”
Section: Acute Toxicity Studiesmentioning
confidence: 97%
“…11,12 In the acute toxicity study, dosages upto1,000 mg/kg did not exhibit any mortality or any signs of toxicity (e.g., changes in body weight and the sum of food consumption) after oral administration of a single dose (Figure 1). This dosage might be considered as the no observed adverse effect level (NOAEL) 8 for DPSUU III. We inspected whether DPSUU III could suppress tumor growth in vivo.…”
Section: Resultsmentioning
confidence: 99%
“…As seen in (Figure 6), DPSUU III uniquely suppressed proliferation of MCF-7 cells at 250 and 500 μg/mL ( Figure 6) (p< 0.05 vs. control).0. 8,11,12 To explain the mechanism of cell growth inhibition by the DPSUU III plant complex, we determined its effect on cell cycle distribution. Exposure of MCF-7 cells to the DPSUU III plant complex resulted in the improvement of the G0-G1 fraction, which was accompanied by a decrease in the S phase ( Figure 7).…”
Section: Resultsmentioning
confidence: 99%